Search
for

    Sort by

    Research 61–90 of 1000+

    1. Multi-Herbal Extracellular Vesicle and Growth Factor Serum for Eyelash Care: A Pilot Randomized, Double Blind, Placebo-Controlled Clinical Study medRxiv · 2026
    2. PCR108 QUALITATIVE AND PSYCHOMETRIC EVALUATION OF THE CLINRO MEASURE FOR EYEBROW HAIR LOSS AND CLINRO MEASURE FOR EYELASH HAIR LOSS IN ADULTS AND ADOLESCENTS WITH SEVERE ALOPECIA AREATA Value in Health · 2026
    3. Baricitinib Provides Holistic Improvement in Scalp, Eyebrow and Eyelash Regrowth in Adolescents With Severe Alopecia Areata SKIN The Journal of Cutaneous Medicine · 2025
    4. Eyebrow and Eyelash Transplantation Using Chalazion Forceps (Dr. Min’s Method) and Importance of Post-Transplant Recovery in Hair Restoration 2025
    5. An Approach to Performing Successful Eyelash Restoration International Society of Hair Restoration Surgery · 2025
    6. Bilateral Eyelash Poliosis with Raccoon Erythema and Hypopigmentation-Contact Follicular Leukoderma Dermatology Practical & Conceptual · 2025
    7. Erlotinib-induced trichomegaly of eyelashes in lung cancer treatment: Epidermal growth factor receptor inhibitor side effect Dermatology Online Journal · 2025
    8. Understanding Eyebrow and Eyelash Involvement in Patients with Alopecia Areata and Responsiveness to Treatment with Baricitinib. PubMed · 2025
    9. Characterization of scalp, eyelash and eyebrow hair regrowth in patients with severe alopecia areata randomized to placebo in brave AA1 and brave AA2 trials JEADV Clinical Practice · 2024
    10. 42752 Evaluation of Eyebrow and Eyelash Regrowth and Patient Satisfaction in the Phase 3 THRIVE-AA1 Trial with CTP-543 (Deuruxolitinib) in Adult Patients with Moderate to Severe Alopecia Areata Journal of the American Academy of Dermatology · 2023
    11. Impact and Management of Loss of Eyebrows and Eyelashes Dermatology and therapy · 2023
    12. 32237 Clinician and patient evaluation of improvement for eyebrow and eyelashes hair loss during baricitinib phase 3 trials BRAVE-AA1 and BRAVE-AA2 Journal of The American Academy of Dermatology · 2022
    13. A qualitative phase I study protocol on developing patient-reported outcome measure for hair, scalp, eyebrows, eyelashes, and beard-related skin disorders medRxiv (Cold Spring Harbor Laboratory) · 2022
    14. Eyelash Trichomegaly: Unusual Feature Associated with Systemic Lupus Erythematosus Patient Case reports in medicine · 2022
    15. GREEN TEA EXTRACT IN AN EYELASH GROWTH ENHANCER GEL FORMULATION: STABILITY TEST, EYE IRRITATION TEST, AND HUMAN EYELASH GROWTH ACTIVITY Asian journal of pharmaceutical and clinical research · 2017
    16. Corneal punctate epitheliopathy secondary to trichiasis following eyelash transplantation Canadian journal of ophthalmology · 2012
    17. Long-term safety and efficacy of Latisse (bimatoprost 0.03% solution) for treatment of eyelash hypotrichosis in subjects with chemotherapy induced and idiopathic hypotrichosis Journal of The American Academy of Dermatology · 2012
    18. Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata Journal of The American Academy of Dermatology · 2009 · 55 citations
    19. Biology of the eyelash hair follicle: an enigma in plain sight 2015 · 34 citations
    20. Eyelash alopecia areata: case series and literature review Canadian journal of ophthalmology · 2012 · 11 citations
    21. Postburns hair restoration of eyebrow, eyelash, moustache, beard and scalp areas Indian journal of burns · 2015 · 3 citations
    22. 42004 Scalp, eyebrow, and eyelash hair regrowth with continued ritlecitinib treatment among patients with alopecia areata without target efficacy response at Week 24: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations
    23. 42005 Sustained scalp, eyebrow, and eyelash hair regrowth with ritlecitinib through Week 48 in patients with alopecia areata: post hoc analysis of the ALLEGRO phase 2b/3 study Journal of the American Academy of Dermatology · 2023 · 1 citations
    24. 26143 Time to scalp hair, eyebrow, and eyelash improvement in patients with alopecia areata treated with baricitinib in the phase 2 portion of the phase 2/3 BRAVE-AA1 study Journal of The American Academy of Dermatology · 2021 · 1 citations
    25. 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM Journal of the American Academy of Dermatology · 2026
    26. 63532 Impact of Eyebrow and Eyelash Hair Loss on Health-Related Quality of Life Among Patients with Alopecia Areata: Results From a Real-World Survey in 5 European Countries Journal of the American Academy of Dermatology · 2025
    27. 52709 Patient-Reported Outcomes for Scalp, Eyebrow and Eyelash Hair Loss in Patients with Severe Alopecia Areata Treated with Baricitinib: 152 Week Results from two Phase 3 Clinical Trials Journal of the American Academy of Dermatology · 2024
    28. 52898 Among scalp non-responder patients with eyebrow/eyelash regrowth in the first year, continued treatment with baricitinib resulted in meaningful scalp responses for patients with severe alopecia areata Journal of the American Academy of Dermatology · 2024
    29. 52874 Timing of eyebrow and eyelash regrowth among subgroups of scalp responders during treatment of severe alopecia areata with baricitinib Journal of the American Academy of Dermatology · 2024
    30. Progressive Eyelash Loss and Scale of the Right Eyelid Cutis · 2024